(c) 2024 PillSync.com

diclofenac sodium tablet delayed release

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of diclofenac and other treatment options before deciding to use diclofenac sodium delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Diclofenac is indicated: For relief of signs and symptoms of osteoarthritis For relief of signs and symptoms of rheumatoid arthritis For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis

aphena pharma solutions - tennessee, inc.


5 years ago ROUND WHITE CTI 102 diclofenac sodium tablet delayed release

ROUND WHITE CTI 102

HOW SUPPLIED Repackaged by Aphena Pharma Solutions - TN. See Repackaging Information for available configurations. Diclofenac sodium delayed-release tablets 50 mg - white to off-white, biconvex, round-shaped, unscored (imprinted "CTI 102" on one side), supplied in bottles of 180 NDC 42291-230-18 1000 NDC 42291-230-10 75 mg - white to off-white, biconvex, round shaped, unscored (imprinted "CTI 103" on one side), supplied in bottles of 180 NDC 42291-231-18 1000 NDC 42291-231-10 Store at 20° to 25°C (68° to 77°F) (see USP Controlled Room Temperature). Protect from moisture. Dispense in a tight, light-resistant container. Manufactured by: Carlsbad Technology, Inc. Carlsbad, CA 92008 USA Distributed by: AvKARE Inc. Pulaski, TN 38478 Revised: February 2010 CTI-11 Rev. C AK02-11 Printed in USA


More pills like ROUND CTI 102

Related Pills

diclofenac sodium tablet delayed release

aphena pharma solutions - tennessee, inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site